Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.   From 1st July 2014, Mawdsleys  will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly.   As from this date, all orders for M&A products…

As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that…